Dataset Viewer
Auto-converted to Parquet Duplicate
_id
string
corpus
string
question
string
answer
string
question_language
string
context_language
string
mode
string
persona
string
generator_model_id
string
generator_model_name
string
candidate_id
string
source_unit_id
string
source_document_id
string
generation_target_id
string
evidence
string
evidence_language
string
supporting_text
string
supporting_text_origin
string
support_match_status
string
document_text
string
document_title
string
generation_source_text
string
generation_support_match_status
string
articles_involved_raw
string
grading_status
string
quality_audit_status
string
faithfulness_verifier_model
string
quality_verifier_model
string
persona_metadata_json
string
metadata_json
string
provenance_json
string
is_best
bool
answer_is_translation
bool
evidence_is_translation
bool
multi_article
bool
multi_article_declared
bool
multi_article_conflict
bool
cross_act
bool
cross_act_declared
bool
multi_source_unit
bool
candidate_rank
int64
support_start
int64
support_end
int64
num_involved_articles
int64
involved_article_ids
list
involved_source_unit_ids
list
unresolved_article_references
list
faith_overall
float64
qual_overall
float64
total_score
float64
evidence_all_languages
dict
evidence_alignment_status
dict
evidence_alignment_eligibility
string
evidence_alignment_contract
string
evidence_en
list
evidence_de
list
evidence_es
list
evidence_fr
list
evidence_zh
list
q_457b2ead5d495d1a66d560afc793125f19782c4f9358f2befc6f7ef1b3d68326
chemistry
¿Qué función se atribuye preferentemente a las amidina-amidas de naftaleno descritas en aplicaciones cosméticas?
Los compuestos son utiles para diferentes propositos, preferentemente como absorbentes de UV para aplicaciones cosmeticas.
es
es
conceptual
conceptual
gpt-5.6-luna
MX-2008001188-A_es
MX-2008001188-A_es
MX-2008001188-A_es
Los compuestos son utiles para diferentes propositos, preferentemente como absorbentes de UV para aplicaciones cosmeticas.
es
Los compuestos son utiles para diferentes propositos, preferentemente como absorbentes de UV para aplicaciones cosmeticas.
evidence
exact
Se describen amidina-amidas de naftaleno de la formula (ver formula) en donde R1, R2, R3, R4, R5 y R6 independientemente entre si son hidrogeno, o C1-C37alquilo; en donde uno a 10 de las unidades de CH2 del C1-C37alquilo independientemente entre si se puede sustituir por grupos carbonilo; atomos de oxigeno, atomos de a...
Se describen amidina-amidas de naftaleno de la formula (ver formula) en donde R1, R2, R3, R4, R5 y R6 independientemente entre si son hidrogeno, o C1-C37alquilo; en donde uno a 10 de las unidades de CH2 del C1-C37alquilo independientemente entre si se puede sustituir por grupos carbonilo; atomos de oxigeno, atomos de a...
exact
clear
{"anchor": "amidina-amidas de naftaleno descritas", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.68", "decider_counts_before_json": "{\"assertion_verification\": 1, \"comparison\": 1, \"conceptual\": 0, \"constraint_search\": 0,...
{"anchor": "amidina-amidas de naftaleno descritas", "answer": "Los compuestos son utiles para diferentes propositos, preferentemente como absorbentes de UV para aplicaciones cosmeticas.", "answer_is_translation": "false", "assertion": "", "assertion_status": "", "candidate_id": "", "candidate_rank": "1", "comparison_as...
{"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 2, "model": "gpt-5.6-luna"}
null
false
null
false
null
false
false
null
false
1
3,556
3,678
0
[]
[ "MX-2008001188-A_es" ]
[]
12
20
32
{ "en": [ { "source_unit_id": "MX-2008001188-A_en", "language": null, "text": "The compounds are useful for different purposes, preferably as UV absorbers for cosmetic applications.", "anchor_id": "a_bae1242ef56099dbbafb7e795322bb4cbf5104c07606570f910e812fc547d009", "origin": "cross_...
{ "en": [ { "source_unit_id": "MX-2008001188-A_en", "anchor_id": "a_bae1242ef56099dbbafb7e795322bb4cbf5104c07606570f910e812fc547d009", "status": "matched", "alignment_id": "t_bc47f1eac1d12acdc0c7e5abfe75dd242dd9d103b0af00b74498d27098723ab1:a_bae1242ef56099dbbafb7e795322bb4cbf5104c07606570f...
eligible
cross_language_evidence_terra_v1
[ "The compounds are useful for different purposes, preferably as UV absorbers for cosmetic applications." ]
[]
[ "Los compuestos son utiles para diferentes propositos, preferentemente como absorbentes de UV para aplicaciones cosmeticas." ]
[]
[]
q_4158552ba9bc172e36cf4cd7ef5a4fd59b89794020c07eb1e596df0d5d457f99
chemistry
¿Qué método permite sintetizar materiales zeolíticos de poro grande relacionados estructuralmente con la zeolita Beta?
El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opcionalmente H¿2?O2, un catión orgánico director de estructura, una fuente de aniones F?-¿ y agua, no siendo necesaria la prese...
es
es
process_retrieval
process_retrieval
gpt-5.6-luna
WO-9940026-A1_es
WO-9940026-A1_es
WO-9940026-A1_es
El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opcionalmente H¿2?O2, un catión orgánico director de estructura, una fuente de aniones F?-¿ y agua, no siendo necesaria la prese...
es
El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opcionalmente H¿2?O2, un catión orgánico director de estructura, una fuente de aniones F?-¿ y agua, no siendo necesaria la prese...
evidence
exact
En la presente invención se reivindican métodos de síntesis de materiales zeolíticos de poro grande relacionados estructuralmente con la zeolita Beta, caracterizados por el relativamente bajo pH del medio de síntesis y la utilización de aniones F- como mineralizante, y a los materiales obtenidos, caracterizados por su ...
En la presente invención se reivindican métodos de síntesis de materiales zeolíticos de poro grande relacionados estructuralmente con la zeolita Beta, caracterizados por el relativamente bajo pH del medio de síntesis y la utilización de aniones F- como mineralizante, y a los materiales obtenidos, caracterizados por su ...
exact
repair
{"anchor": "materiales zeolíticos de poro grande relacionados estructuralmente con la zeolita Beta", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.8", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\":...
{"anchor": "materiales zeolíticos de poro grande relacionados estructuralmente con la zeolita Beta", "answer": "El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opcionalmente H¿...
{"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 3, "model": "gpt-5.6-luna"}
null
false
null
false
null
false
false
null
false
1
803
1,150
0
[]
[ "WO-9940026-A1_es" ]
[]
12
18
30
{ "en": [], "de": [], "es": [ { "source_unit_id": "WO-9940026-A1_es", "language": "es", "text": "El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opc...
{ "en": [], "de": [], "es": [ { "source_unit_id": "WO-9940026-A1_es", "anchor_id": "a_5c677d5b766371b0dc85c2a976edf33dac2bfdcb754bdac74156e7fb9d99ee5a", "status": "source_exact", "alignment_id": null, "task_id": null, "request_hash": null, "validation_status": null, ...
eligible
cross_language_evidence_terra_v1
[]
[]
[ "El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opcionalmente H¿2?O2, un catión orgánico director de estructura, una fuente de aniones F?-¿ y agua, no siendo necesaria la ...
[ "Le procédé consiste à chauffer à une température allant de 363 à 473K un mélange réactionnel contenant une source d'au moins un élément tétravalent (T(IV), éventuellement une source d'un élément T(III), éventuellement H¿2?O2, un cation organique structurant, une source d'anions F?-¿ et de l'eau, la présence de cat...
[]
q_851753b284960b6549f9dc5c4cf2602947f061dfe994c42d21acd8ed27b13931
chemistry
哪份专利公开文本描述了包含至少一种式I的取代3-羟基甲基吡啶化合物或其盐,以及至少一种其它杀真菌活性化合物II的杀真菌活性化合物混合物,其中式I中的X为O、S或NR4?
CN-101909442-A
zh
zh
source_finding
source_finding
gpt-5.6-luna
CN-101909442-A_zh
CN-101909442-A_zh
CN-101909442-A_zh
本发明涉及包含至少一种式I的取代的3-羟基甲基吡啶化合物或其盐和至少一种其它杀真菌活性化合物II的杀真菌活性化合物的混合物。其中X为O、S或NR 4 ;R 1 为C 1 -C 6 烷基、C 1 -C 6 烷氧基-C 1 -C 6 烷基、C 1 -C 6 卤代烷基、芳基-C 1 -C 4 烷基、芳氧基-C 1 -C 4 烷基、芳硫基-C 1 -C 4 烷基、芳基或杂芳基,其中后5个基团的环状结构部分未被取代或被1、2或3个选自如下的基团取代:卤素、C 1 -C 4 烷基、C 2 -C 4 链烯基、C 2 -C 4 炔基、C 1 -C 4 卤代烷基、C 1 -C 4 烷氧基、C 1 -C 4 烷硫基、C 1 -C 4 卤代烷氧基、C 1...
zh
本发明涉及包含至少一种式I的取代的3-羟基甲基吡啶化合物或其盐和至少一种其它杀真菌活性化合物II的杀真菌活性化合物的混合物。其中X为O、S或NR 4 ;R 1 为C 1 -C 6 烷基、C 1 -C 6 烷氧基-C 1 -C 6 烷基、C 1 -C 6 卤代烷基、芳基-C 1 -C 4 烷基、芳氧基-C 1 -C 4 烷基、芳硫基-C 1 -C 4 烷基、芳基或杂芳基,其中后5个基团的环状结构部分未被取代或被1、2或3个选自如下的基团取代:卤素、C 1 -C 4 烷基、C 2 -C 4 链烯基、C 2 -C 4 炔基、C 1 -C 4 卤代烷基、C 1 -C 4 烷氧基、C 1 -C 4 烷硫基、C 1 -C 4 卤代烷氧基、C 1...
evidence
exact
本发明涉及包含至少一种式I的取代的3-羟基甲基吡啶化合物或其盐和至少一种其它杀真菌活性化合物II的杀真菌活性化合物的混合物。其中X为O、S或NR 4 ;R 1 为C 1 -C 6 烷基、C 1 -C 6 烷氧基-C 1 -C 6 烷基、C 1 -C 6 卤代烷基、芳基-C 1 -C 4 烷基、芳氧基-C 1 -C 4 烷基、芳硫基-C 1 -C 4 烷基、芳基或杂芳基,其中后5个基团的环状结构部分未被取代或被1、2或3个选自如下的基团取代:卤素、C 1 -C 4 烷基、C 2 -C 4 链烯基、C 2 -C 4 炔基、C 1 -C 4 卤代烷基、C 1 -C 4 烷氧基、C 1 -C 4 烷硫基、C 1 -C 4 卤代烷氧基、C 1...
本发明涉及包含至少一种式I的取代的3-羟基甲基吡啶化合物或其盐和至少一种其它杀真菌活性化合物II的杀真菌活性化合物的混合物。其中X为O、S或NR 4 ;R 1 为C 1 -C 6 烷基、C 1 -C 6 烷氧基-C 1 -C 6 烷基、C 1 -C 6 卤代烷基、芳基-C 1 -C 4 烷基、芳氧基-C 1 -C 4 烷基、芳硫基-C 1 -C 4 烷基、芳基或杂芳基,其中后5个基团的环状结构部分未被取代或被1、2或3个选自如下的基团取代:卤素、C 1 -C 4 烷基、C 2 -C 4 链烯基、C 2 -C 4 炔基、C 1 -C 4 卤代烷基、C 1 -C 4 烷氧基、C 1 -C 4 烷硫基、C 1 -C 4 卤代烷氧基、C 1...
exact
clear
{"anchor": "包含至少一种式I的取代3-羟基甲基吡啶化合物或其盐,以及至少一种其它杀真菌活性化合物II的杀真菌活性化合物混合物", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.66", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\": 1, \"conceptual\": 0, \"cons...
{"anchor": "包含至少一种式I的取代3-羟基甲基吡啶化合物或其盐,以及至少一种其它杀真菌活性化合物II的杀真菌活性化合物混合物", "answer": "CN-101909442-A", "answer_is_translation": "false", "assertion": "", "assertion_status": "", "candidate_id": "", "candidate_rank": "1", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "context_language": "zh", "conte...
{"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 4, "model": "gpt-5.6-luna"}
null
false
null
false
null
false
false
null
false
1
0
883
0
[]
[ "CN-101909442-A_zh" ]
[]
11
20
31
{ "en": [ { "source_unit_id": "CN-101909442-A_en", "language": null, "text": "The present invention relates to mixtures of fungicidally active compounds comprising at least one substituted 3-hydroxymethylpyridine compound of formula I or a salt thereof and at least one further fungicidally activ...
{ "en": [ { "source_unit_id": "CN-101909442-A_en", "anchor_id": "a_b070e0fbc0bf9ed27b2883e98a8865b0867bbaf96762e292377be519c792a712", "status": "matched", "alignment_id": "t_489b87af654322f63a389a6f0f4b4cb8e1e4131c8d64bb89d007a9dd751cd208:a_b070e0fbc0bf9ed27b2883e98a8865b0867bbaf96762e2923...
eligible
cross_language_evidence_terra_v1
[ "The present invention relates to mixtures of fungicidally active compounds comprising at least one substituted 3-hydroxymethylpyridine compound of formula I or a salt thereof and at least one further fungicidally active compound II. Wherein X is O, S or NR 4 ;R 1 Is C 1 -C 6 Alkyl radical, C 1 -C 6 alkoxy-C 1 -C 6...
[]
[]
[]
[ "本发明涉及包含至少一种式I的取代的3-羟基甲基吡啶化合物或其盐和至少一种其它杀真菌活性化合物II的杀真菌活性化合物的混合物。其中X为O、S或NR 4 ;R 1 为C 1 -C 6 烷基、C 1 -C 6 烷氧基-C 1 -C 6 烷基、C 1 -C 6 卤代烷基、芳基-C 1 -C 4 烷基、芳氧基-C 1 -C 4 烷基、芳硫基-C 1 -C 4 烷基、芳基或杂芳基,其中后5个基团的环状结构部分未被取代或被1、2或3个选自如下的基团取代:卤素、C 1 -C 4 烷基、C 2 -C 4 链烯基、C 2 -C 4 炔基、C 1 -C 4 卤代烷基、C 1 -C 4 烷氧基、C 1 -C 4 烷硫基、C 1 -C 4 卤代烷氧...
q_4b397b7324634cd3a66acd8569182fa2ef2a08b33240952e25f7e6699803aed8
chemistry
Welche gemeinsamen zulässigen Substituentenoptionen sind für R 1 und R 3 der Formel I bei den neuen Nitroenamin-Derivaten angegeben?
Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B
de
de
comparison
comparison
gpt-5.6-luna
EP-0453398-A2_de
EP-0453398-A2_de
EP-0453398-A2_de
Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B
de
Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B
evidence
exact
Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B, oder R 3 und R 4 gemeinsam -(CH 2 ) 4...
Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B, oder R 3 und R 4 gemeinsam -(CH 2 ) 4...
exact
clear
{"anchor": "neuen Nitroenamin-Derivaten", "assertion": "", "assertion_status": "", "comparison_aspect": "zulässige Substituentenoptionen", "comparison_entities": "[\"R 1\", \"R 3\"]", "constraints": "", "decider_confidence": "0.78", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\": 0, \"con...
{"anchor": "neuen Nitroenamin-Derivaten", "answer": "Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen...
{"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 5, "model": "gpt-5.6-luna"}
null
false
null
false
null
false
false
null
false
1
0
281
0
[]
[ "EP-0453398-A2_de" ]
[]
11
19
30
{ "en": [ { "source_unit_id": "EP-0453398-A2_en", "language": null, "text": "R1 is hydrogen, C1-C6-alkyl or C3-C6-cycloalkyl, R2 is hydrogen or C1-C6-alkyl, R3 is hydrogen, C1-C6-alkyl or C3-C6-cycloalkyl", "anchor_id": "a_0345d2309f0238d9d6b3d35a869c3aa1ecb695d30544404a613946a759deb2f6", ...
{ "en": [ { "source_unit_id": "EP-0453398-A2_en", "anchor_id": "a_0345d2309f0238d9d6b3d35a869c3aa1ecb695d30544404a613946a759deb2f6", "status": "matched", "alignment_id": "t_f0fcf8abd093aa7c104c1e5caa60e4f4102280c5b38eef95bf0d82438d4b2b7b:a_0345d2309f0238d9d6b3d35a869c3aa1ecb695d30544404a61...
eligible
cross_language_evidence_terra_v1
[ "R1 is hydrogen, C1-C6-alkyl or C3-C6-cycloalkyl, R2 is hydrogen or C1-C6-alkyl, R3 is hydrogen, C1-C6-alkyl or C3-C6-cycloalkyl" ]
[ "Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B" ]
[]
[]
[]
q_1089f9e3f3ace9615b72aeceb2b45f033943c59d8c22ea93e3869c56c3db523d
chemistry
在黄褐斑鼠模型中,CLY系列化合物对皮肤和血中酪氨酸酶水平、皮肤中SCF和C-kit蛋白表达及黄褐斑色素形成有何影响?
动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成
zh
zh
lookup
lookup
gpt-5.6-luna
WO-2022262854-A1_zh
WO-2022262854-A1_zh
WO-2022262854-A1_zh
动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成
zh
动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成
evidence
exact
本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平...
本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平...
exact
clear
{"anchor": "黄褐斑鼠模型", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.76", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\": 0, \"conceptual\": 0, \"constraint_search\": 0, \"lookup\": 0, \"process_retri...
{"anchor": "黄褐斑鼠模型", "answer": "动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成", "answer_is_translation": "false", "assertion": "", "assertion_status": "", "candidate_id": "", "candidate_rank": "1", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "context_language"...
{"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 6, "model": "gpt-5.6-luna"}
null
false
null
false
null
false
false
null
false
1
75
153
0
[]
[ "WO-2022262854-A1_zh" ]
[]
12
20
32
{ "en": [], "de": [], "es": [], "fr": [ { "source_unit_id": "WO-2022262854-A1_fr", "language": null, "text": "le composé série CLY, dans un modèle de souris à chloasma, peut évidemment réduire le niveau de tyrosinase dans la peau et le sang, réduire l'expression du facteur de cellules souc...
{ "en": [], "de": [], "es": [], "fr": [ { "source_unit_id": "WO-2022262854-A1_fr", "anchor_id": "a_4acd57ecbc95f37731ff1596798936d1c553e4592b497a257ac8ce914b141d54", "status": "matched", "alignment_id": "t_947cbef816b817acc6da3015847ee8fda863bd06081ccf81b5b4ff6d4ee223a0:a_4acd57ecbc9...
eligible
cross_language_evidence_terra_v1
[]
[]
[]
[ "le composé série CLY, dans un modèle de souris à chloasma, peut évidemment réduire le niveau de tyrosinase dans la peau et le sang, réduire l'expression du facteur de cellules souches (SCF) et une protéine C-Kit dans la peau, et inhibent la chromogenèse du chloasma" ]
[ "动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成" ]
q_c07a4a959499f3d2e2683908675a7f67292cefc6337a8fc683e97bb6567209af
chemistry
在肺纤维化小鼠模型中,CLY系列化合物能如何改变肺组织中的MMP-2、MMP-9、TIMP-1和VEGF水平,以及外周血中的SOD和CAT酶水平?
能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平,同时可提高外周血中SOD、CAT酶水平
zh
zh
lookup
lookup
gpt-5.6-luna
WO-2022262854-A1_zh
WO-2022262854-A1_zh
WO-2022262854-A1_zh
能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平,同时可提高外周血中SOD、CAT酶水平
zh
能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平,同时可提高外周血中SOD、CAT酶水平
evidence
exact
本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平...
本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平...
exact
clear
{"anchor": "肺纤维化小鼠模型", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.76", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\": 0, \"conceptual\": 0, \"constraint_search\": 0, \"lookup\": 0, \"process_ret...
{"anchor": "肺纤维化小鼠模型", "answer": "能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平,同时可提高外周血中SOD、CAT酶水平", "answer_is_translation": "false", "assertion": "", "assertion_status": "", "candidate_id": "", "candidate_rank": "2", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "context_language": "zh", "c...
{"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 7, "model": "gpt-5.6-luna"}
null
false
null
false
null
false
false
null
false
2
274
340
0
[]
[ "WO-2022262854-A1_zh" ]
[]
12
20
32
{ "en": [], "de": [], "es": [], "fr": [ { "source_unit_id": "WO-2022262854-A1_fr", "language": null, "text": "dans un modèle de souris à fibrose pulmonaire, il peut évidemment réduire les taux de MMP-2 et MMP-9 dans le tissu pulmonaire, augmenter les taux de TIMP-1 et VEGF, et augmenter si...
{ "en": [], "de": [], "es": [], "fr": [ { "source_unit_id": "WO-2022262854-A1_fr", "anchor_id": "a_84d9cece33ac5802b00db4a0617671aeed2fcc8458a14a7b090f71451f97eaae", "status": "matched", "alignment_id": "t_947cbef816b817acc6da3015847ee8fda863bd06081ccf81b5b4ff6d4ee223a0:a_84d9cece33a...
eligible
cross_language_evidence_terra_v1
[]
[]
[]
[ "dans un modèle de souris à fibrose pulmonaire, il peut évidemment réduire les taux de MMP-2 et MMP-9 dans le tissu pulmonaire, augmenter les taux de TIMP-1 et VEGF, et augmenter simultanément les taux d'enzymes SOD et CAT dans le sang périphérique" ]
[ "能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平,同时可提高外周血中SOD、CAT酶水平" ]
q_8e66ce68207c4719bd1aa3ed8730dac5dd7df56e3b1ea066c6b24d009381ef9c
chemistry
在急性GVHD小鼠模型中,CLY系列化合物对小鼠生存时间和临床症状有何影响?是否显示出对急性GVHD的治疗作用?
CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用
zh
zh
lookup
lookup
gpt-5.6-luna
WO-2022262854-A1_zh
WO-2022262854-A1_zh
WO-2022262854-A1_zh
CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用
zh
CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用
evidence
exact
本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平...
本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平...
exact
clear
{"anchor": "急性GVHD小鼠", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.76", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\": 0, \"conceptual\": 0, \"constraint_search\": 0, \"lookup\": 0, \"process_ret...
{"anchor": "急性GVHD小鼠", "answer": "CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用", "answer_is_translation": "false", "assertion": "", "assertion_status": "", "candidate_id": "", "candidate_rank": "3", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "context_language": "zh", "context_languages":...
{"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 8, "model": "gpt-5.6-luna"}
null
false
null
false
null
false
false
null
false
3
225
273
0
[]
[ "WO-2022262854-A1_zh" ]
[]
12
19
31
{ "en": [], "de": [], "es": [], "fr": [ { "source_unit_id": "WO-2022262854-A1_fr", "language": null, "text": "Le composé série CLY peut prolonger de manière significative le temps de survie de souris à GVH aiguë, et peut réduire les symptômes cliniques, présentant un effet thérapeutique su...
{ "en": [], "de": [], "es": [], "fr": [ { "source_unit_id": "WO-2022262854-A1_fr", "anchor_id": "a_969801ee8359f903a39cacb4934eb7080dbc723a8a9dd32df91a75d0c21edbff", "status": "matched", "alignment_id": "t_947cbef816b817acc6da3015847ee8fda863bd06081ccf81b5b4ff6d4ee223a0:a_969801ee835...
eligible
cross_language_evidence_terra_v1
[]
[]
[]
[ "Le composé série CLY peut prolonger de manière significative le temps de survie de souris à GVH aiguë, et peut réduire les symptômes cliniques, présentant un effet thérapeutique sur GVH aigu" ]
[ "CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用" ]
q_7612f250d4f1141b2de506bb3eaf24391b1e7e497bc9c4c562564df99218202a
chemistry
"¿Se ha divulgado un método para producir una lámina de acero recubierta con zinc o aleación de (...TRUNCATED)
"Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resis(...TRUNCATED)
es
es
assertion_verification
assertion_verification
gpt-5.6-luna
MX-2019015511-A_es
MX-2019015511-A_es
MX-2019015511-A_es
"Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resis(...TRUNCATED)
es
"Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resis(...TRUNCATED)
evidence
exact
"Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resis(...TRUNCATED)
"Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resis(...TRUNCATED)
exact
clear
"{\"anchor\": \"método para producir una lámina de acero recubierta con zinc o aleación de zinc\"(...TRUNCATED)
"{\"anchor\": \"método para producir una lámina de acero recubierta con zinc o aleación de zinc\"(...TRUNCATED)
"{\"file\": \"data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_ge(...TRUNCATED)
null
false
null
false
null
false
false
null
false
1
0
2,242
0
[]
[ "MX-2019015511-A_es" ]
[]
11
20
31
{"en":[{"source_unit_id":"MX-2019015511-A_en","language":null,"text":"soaking the sheet at T2, then (...TRUNCATED)
{"en":[{"source_unit_id":"MX-2019015511-A_en","anchor_id":"a_e9a3a61c550d42a306f427df6fed30101a00296(...TRUNCATED)
eligible
cross_language_evidence_terra_v1
["soaking the sheet at T2, then cooling the sheet at a rate comprised between 10 and 400°C/s, then (...TRUNCATED)
[]
["Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resi(...TRUNCATED)
[]
[]
q_1e6b2c946a72c20c78192a544d485fce99c70527e1ca2ca1d12893bfba5c6c84
chemistry
"Dans le traitement thermique en four d’un matériau pulvérulent destiné notamment à la product(...TRUNCATED)
"Le coefficient Ζ de remplissage de la section transversale du tambour avec le matériau pulvérule(...TRUNCATED)
fr
fr
lookup
lookup
gpt-5.6-luna
WO-9738948-A1_fr
WO-9738948-A1_fr
WO-9738948-A1_fr
"Le coefficient Ζ de remplissage de la section transversale du tambour avec le matériau pulvérule(...TRUNCATED)
fr
"Le coefficient Ζ de remplissage de la section transversale du tambour avec le matériau pulvérule(...TRUNCATED)
evidence
exact
"Procédé pour le traitement thermique d'un matériau dispersé ou pulvérulent, dans lequel on pr(...TRUNCATED)
"Procédé pour le traitement thermique d'un matériau dispersé ou pulvérulent, dans lequel on pr(...TRUNCATED)
exact
clear
"{\"anchor\": \"coefficient Ζ de remplissage de la section transversale du tambour avec le matéria(...TRUNCATED)
"{\"anchor\": \"coefficient Ζ de remplissage de la section transversale du tambour avec le matéria(...TRUNCATED)
"{\"file\": \"data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_ge(...TRUNCATED)
null
false
null
false
null
false
false
null
false
1
580
1,197
0
[]
[ "WO-9738948-A1_fr" ]
[]
12
20
32
{"en":[],"de":[],"es":[{"source_unit_id":"WO-9738948-A1_es","language":null,"text":"El coeficiente (...TRUNCATED)
{"en":[],"de":[],"es":[{"source_unit_id":"WO-9738948-A1_es","anchor_id":"a_584e688e5ef3dec05d3fb0338(...TRUNCATED)
eligible
cross_language_evidence_terra_v1
[]
[]
["El coeficiente Ζ de llenado de la sección transversal del tambor por el material disperso se eli(...TRUNCATED)
["Le coefficient Ζ de remplissage de la section transversale du tambour avec le matériau pulvérul(...TRUNCATED)
[]
q_aa95f01681be391ea84446fa7a5971d69e2998f8d21b38b7114b849a25aa5d5e
chemistry
"What sustainable-material packaging architecture can house water-soluble detergent capsules while p(...TRUNCATED)
"Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of di(...TRUNCATED)
en
en
constraint_search
constraint_search
gpt-5.6-luna
ES-1310953-U_en
ES-1310953-U_en
ES-1310953-U_en
"Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of di(...TRUNCATED)
en
"Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of di(...TRUNCATED)
evidence
exact
"Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of di(...TRUNCATED)
"Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of di(...TRUNCATED)
exact
clear
"{\"anchor\": \"water-soluble detergent capsules\", \"assertion\": \"\", \"assertion_status\": \"\",(...TRUNCATED)
"{\"anchor\": \"water-soluble detergent capsules\", \"answer\": \"Packaging for water-soluble deterg(...TRUNCATED)
"{\"file\": \"data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_ge(...TRUNCATED)
null
false
null
false
null
false
false
null
false
1
0
2,024
0
[]
[ "ES-1310953-U_en" ]
[]
12
20
32
{"en":[{"source_unit_id":"ES-1310953-U_en","language":"en","text":"Packaging for water-soluble deter(...TRUNCATED)
{"en":[{"source_unit_id":"ES-1310953-U_en","anchor_id":"a_b3700a4f180d47aff4c42583884653433095922a20(...TRUNCATED)
eligible
cross_language_evidence_terra_v1
["Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of d(...TRUNCATED)
[]
["Embalaje para cápsulas hidrosolubles de detergente que comprende un cuerpo (10) materializado med(...TRUNCATED)
[]
[]
End of preview. Expand in Data Studio

Multilingual generated QAs and source corpora

Multilingual supporting evidence

The qas configuration now includes native nested evidence_all_languages and evidence_alignment_status fields with the five keys en, de, es, fr, and zh. Each language contains a list of span/status objects; an unavailable language has an empty list. Original questions, answers, metadata, and corpus records are preserved. Arabic and Russian corpus versions remain available where previously published; this alignment run did not create evidence in those languages.

For easy reading, evidence_en, evidence_de, evidence_es, evidence_fr, and evidence_zh contain lists of the exact passage strings. A corpus-specific readable CSV contains these fields alongside questions and answers. In its readable language columns, one span is plain text, no span is an empty cell, and multiple spans use a JSON list. Native Parquet columns always remain lists. No span strings are joined, translated, or normalized.

Original supporting text is marked source_exact. Generated spans are literal matches in the linked target document and remain pending_review: exact quotation does not establish semantic equivalence or independent human review. The language-specific status lists retain unsuccessful/uncertain alignments and their provenance. evidence_alignment_eligibility explains excluded QAs (for example, missing exact original support or a quarantined language label); such questions remain in the dataset without invented evidence. The contract is cross_language_evidence_terra_v1. Legacy evidence/evidence_language columns and the separate evidence configuration keep their previous interpretation.

from datasets import load_dataset

qas = load_dataset("MehdiAstaraki/chemistry-generated-qa", "qas", split="train")
row = next(row for row in qas if row["evidence_all_languages"]["en"])
print(row["question"])
print(row["evidence_all_languages"]["en"][0]["text"])
print(row["evidence_en"])

This update adds supporting passages only. It creates no retrieval chunks or new relevance judgments, and does not change source_qrels.

Contains documents associated with the published questions and their available translations. This QA release does not include the complete retrieval haystack.

All supplied generator candidates are retained, including low-scoring and unmatched evidence. The train split is a storage convention; no leakage-safe evaluation split has been assigned. Before splitting, group questions from the same article/act, UN document, or patent and its translation partners to avoid source and generator leakage.

Configurations

  • qas: 1,950 rows

  • evidence: 1,950 rows

  • source_qrels: 4,033 rows

  • corpus: 409 rows

  • qas: questions, answers, raw evidence, persona/mode, model, scores, source IDs and involvement. document_text embeds the complete primary source unit; additional involved units are linked through involved_source_unit_ids to corpus. metadata_json preserves the complete input row, including persona-specific fields, prompts, grading responses, routing decisions and generation references. provenance_json identifies the input file and row/task. CSV metadata preserves its original string types.

  • evidence: canonical supporting text: explicit evidence where present, otherwise answer. origin distinguishes the two. start and end refer to the original corpus unit's text, in Unicode code points, end-exclusive; only the first exact match receives offsets. Matching checks only presence (exact or whitespace-normalized), not factual entailment. Support is checked against the primary source, not every involved/translated document.

  • corpus: _id, text, language, source/parent IDs, unit type and original metadata. EUR-Lex units are full articles (or explicitly involved annexes); patent units are title + abstract; UN units are entire documents joined from the original aligned lines. UN block IDs/ranges survive in QA metadata only. EUR-Lex duplicate ELI/language records use the last occurrence, matching the generation loader. Source text and patent markup are retained.

  • source_qrels: positive source-unit associations derived from generation provenance, plus existing language versions of each legal unit / directly accepted chemistry translation partners. They are not manually judged relevance or chunk-level qrels. score=1 indicates an association; absent judgments do not establish irrelevance. Supplied contextual references alone do not create positives. Chemistry partners are not expanded transitively.

involved_source_unit_ids includes the primary source and explicitly involved EUR-Lex units; involved_article_ids includes article ELIs only. multi_article is true when multiple articles are resolved or the generator declared it. multi_article_declared retains that declaration; multi_article_conflict identifies a disagreement with the resolved article count. cross_act means involvement across acts; multi_source_unit also covers an article plus an annex. A translation into another language does not count as another involved article. UN and chemistry have no article-involvement annotation, so their multi_article is false and multi_article_declared is null; supplied UN references are retained only as metadata.

These source units have not yet been chunked. Create retrieval chunks with a pinned tokenizer (e.g. BAAI/bge-m3), preserve parent IDs and character ranges, and align evidence to those chunks. Do not mark every chunk of a source document relevant. Unmatched or translated evidence needs separate alignment/review before it can establish chunk-level judgments.

manifest.json records export inputs and SHA-256 hashes; report.json records coverage, models, personas, evidence matching and multi-article statistics. No upstream license is assigned to generated material by this exporter.

Attribution and source terms

BASF-AI AI4Chem abstract pairs

  • Source dataset: BASF-AI/ai4chem-clir-google-patents-within-document-abstract-pairs, maintained by BASF-AI. The upstream dataset contains pairs of cleaned abstracts from the same Google Patents publication.
  • Selection: This derived corpus retains pairs with pair_ok=true and judge_verdict equal to exact or high, with both endpoints in English, German, French, Spanish or Chinese. Retrieval positives follow the accepted direct pair links.
  • Provenance: The corpus preserves the upstream dataset revision, corpus and group identifiers, accepted pair identifiers and paired document identifiers. Questions, answers and grading are generated by this benchmark pipeline.
  • Terms: The upstream dataset card does not establish a verified license for these paired records or their underlying patent text. Consult the upstream dataset and the applicable source terms; this notice does not assign a license or import a historical BigQuery license claim.
  • No endorsement: This benchmark is independent of BASF-AI and the providers of the underlying patent publications.
Downloads last month
151